Jumaah Mohammed Dhari, Shuhata Mahmood Hasen, Al-Hamndawee Daniah Majid, Al-Ani Ibrahim Issam, Al-Hadeethi Ahmed Mohammed
Department of Surgery, Abu Ghraib General Hospital, Baghdad, Iraq.
Dean of College of Nursing, Al- Hadi University, Baghdad, Iraq.
BMC Surg. 2025 Aug 12;25(1):369. doi: 10.1186/s12893-025-03127-w.
Surgical site infection (SSI) is a common complication following open appendectomy, particularly in low and middle income countries. Intraoperative wound irrigation with antibiotic solutions has been used as a preventive strategy, though its efficacy remains debated.
To evaluate the effectiveness of intraoperative wound irrigation using a combination of ceftriaxone and metronidazole in reducing SSIs after open appendectomy, compared to normal saline irrigation.
A double-blind randomized controlled trial was conducted between July 2023 and December 2024 at Abu Ghraib General Hospital. A total of 410 patients aged 15-50 years with acute appendicitis undergoing open appendectomy were randomized into two groups. The experimental group received layer by layer irrigation with ceftriaxone and metronidazole, while the control group received saline irrigation. Postoperative follow-up was conducted on days 10, 15, and 30 to assess the incidence of SSIs using CDC criteria.
There was no statistically significant difference in SSI rates between the experimental and control groups (4.1% vs. 6.6%; p = 0.278). Among patients with perforated appendices, SSI rates remained statistically insignificant between the two groups. Preoperative CRP and WBC levels were significantly higher in patients who developed SSIs (p < 0.0001). No significant difference was observed in hospital stay duration between the groups.
Intraoperative wound irrigation with ceftriaxone and metronidazole did not significantly reduce SSI incidence compared to saline irrigation in open appendectomy. Routine use of antibiotic irrigation may not be justified.
The study was retrospectively registered with the International Standard Randomised Controlled Trial Number (ISRCTN) registry under the registration number ISRCTN19878512 on 19 May 2025.
手术部位感染(SSI)是开放性阑尾切除术后常见的并发症,在低收入和中等收入国家尤为常见。术中用抗生素溶液冲洗伤口一直被用作一种预防策略,但其疗效仍存在争议。
与生理盐水冲洗相比,评估头孢曲松和甲硝唑联合术中伤口冲洗在降低开放性阑尾切除术后手术部位感染方面的有效性。
2023年7月至2024年12月在阿布格莱布总医院进行了一项双盲随机对照试验。共有410例年龄在15至50岁之间、患有急性阑尾炎且接受开放性阑尾切除术的患者被随机分为两组。实验组接受头孢曲松和甲硝唑逐层冲洗,而对照组接受生理盐水冲洗。术后第10天、15天和30天进行随访,使用美国疾病控制与预防中心(CDC)标准评估手术部位感染的发生率。
实验组和对照组的手术部位感染率无统计学显著差异(4.1%对6.6%;p = 0.278)。在阑尾穿孔的患者中,两组之间的手术部位感染率在统计学上仍无显著差异。发生手术部位感染的患者术前C反应蛋白(CRP)和白细胞(WBC)水平显著更高(p < 0.0001)。两组之间的住院时间无显著差异。
与开放性阑尾切除术中生理盐水冲洗相比,头孢曲松和甲硝唑术中伤口冲洗并未显著降低手术部位感染的发生率。抗生素冲洗的常规使用可能不合理。
该研究于2025年5月19日在国际标准随机对照试验编号(ISRCTN)注册中心进行回顾性注册,注册号为ISRCTN19878512。